康莱特联合支气管动脉灌注栓塞治疗肺癌的临床效果观察  

Clinical effect observation of Kanglaite combined with bronchial artery embolization in the treatment of lung cancer

作　　者：聂宁陵 Nie Ningling(Department of Oncology,the Affiliated Hospital of Yongzhou Vocational Technical College,Hunan Province 425006)

机构地区：[1]湖南省永州职业技术学院附属医院肿瘤科,425006

出　　处：《中国社区医师》2017年第2期46-47,共2页Chinese Community Doctors

摘　　要：目的:探讨康莱特联合支气管动脉灌注栓塞治疗肺癌的临床疗效。方法:收治肺癌患者80例,按不同治疗方法分为两组,每组40例。两组患者给予支气管动脉灌注栓塞治疗,观察组在此基础上给予康莱特治疗,比较两组患者临床疗效、1年内生存率、不良反应情况。结果:观察组1年内生存率,治疗总有效率明显高于对照组(P<0.05);观察组不良反应率明显低于对照组(P<0.05)。结论:康莱特联合支气管动脉灌注栓治疗肺癌患者可取得显著临床疗效,且用药安全,不良反应小。Objective:To explore the clinical curative effect of Kanglaite combined with bronchial artery embolization in the treatment of lung cancer.Methods:80 patients with lung cancer were selected.According to different treatment methods,they were divided into two groups with 40 cases in each.The two groups were given bronchial artery embolization treatment.The observation group was given Kanglaite treatment on this basis.The clinical curative effect,1 year survival rate,adverse reaction were compared between groups.Results:The 1 year survival rate and total effective rate of the observation group were significantly higher than those of the control group(P<0.05).The adverse reaction rate of the observation group was significantly lower than that of the control group(P<0.05).Conclusion:Kanglaite combined with bronchial artery embolization in the treatment of lung cancer can obtain significant clinical curative effect.The medication is safe,and the adverse reaction is less.

关 键 词：康莱特 支气管动脉灌注栓塞 肺癌 

分 类 号：R734.2[医药卫生—肿瘤]